The antimalarial ferroquine: from bench to clinic

Ferroquine (FQ, SSR97193) is currently the most advanced organometallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocenecontaining compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falcip...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Biot, C., Nosten, F., Fraisse, L., Ter-Minassian, D., Khalife, J., Dive, D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: EDP Sciences 2011
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671469/
https://ncbi.nlm.nih.gov/pubmed/21894260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1051/parasite/2011183207
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller